[go: up one dir, main page]

MX2021001562A - Excipiente de alto rendimiento que comprende celulosa microcristalina co-procesada y carbonato de calcio reaccionado en superficie. - Google Patents

Excipiente de alto rendimiento que comprende celulosa microcristalina co-procesada y carbonato de calcio reaccionado en superficie.

Info

Publication number
MX2021001562A
MX2021001562A MX2021001562A MX2021001562A MX2021001562A MX 2021001562 A MX2021001562 A MX 2021001562A MX 2021001562 A MX2021001562 A MX 2021001562A MX 2021001562 A MX2021001562 A MX 2021001562A MX 2021001562 A MX2021001562 A MX 2021001562A
Authority
MX
Mexico
Prior art keywords
excipient
calcium carbonate
high performance
microcrystalline cellulose
reacted calcium
Prior art date
Application number
MX2021001562A
Other languages
English (en)
Inventor
Miguel Laura De
Stefan Lander
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP18194903.3A external-priority patent/EP3622966A1/en
Priority claimed from EP19152843.9A external-priority patent/EP3682901A1/en
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of MX2021001562A publication Critical patent/MX2021001562A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/015—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/262—Cellulose; Derivatives thereof, e.g. ethers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a un excipiente farmacéutico particulado o nutracéutico, un proceso para la preparación de un excipiente farmacéutico particulado o nutracéutico, una composición farmacéutica o nutracéutica que comprende el excipiente farmacéutico particulado o nutracéutico, así como un proceso para elaborar una composición farmacéutica o nutracéutica.
MX2021001562A 2018-09-17 2019-09-17 Excipiente de alto rendimiento que comprende celulosa microcristalina co-procesada y carbonato de calcio reaccionado en superficie. MX2021001562A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18194903.3A EP3622966A1 (en) 2018-09-17 2018-09-17 High performance excipient comprising co-processed microcrystalline cellulose and surface-reacted calcium carbonate
EP19152843.9A EP3682901A1 (en) 2019-01-21 2019-01-21 High performance excipient comprising co-processed microcrystalline cellulose and surface-reacted calcium carbonate
PCT/EP2019/074834 WO2020058252A1 (en) 2018-09-17 2019-09-17 High performance excipient comprising co-processed microcrystalline cellulose and surface-reacted calcium carbonate

Publications (1)

Publication Number Publication Date
MX2021001562A true MX2021001562A (es) 2021-06-08

Family

ID=67982086

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021001562A MX2021001562A (es) 2018-09-17 2019-09-17 Excipiente de alto rendimiento que comprende celulosa microcristalina co-procesada y carbonato de calcio reaccionado en superficie.

Country Status (10)

Country Link
US (1) US12115258B2 (es)
EP (1) EP3852807B1 (es)
JP (1) JP2022500450A (es)
KR (1) KR20210061379A (es)
CN (2) CN112770777A (es)
AU (1) AU2019341523A1 (es)
BR (1) BR112021002719A2 (es)
IL (1) IL281421A (es)
MX (1) MX2021001562A (es)
WO (1) WO2020058252A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111333875B (zh) * 2020-04-13 2023-02-07 牡丹江霖润药用辅料有限责任公司 一种超细的高性能微晶纤维素产品及其制备方法
TW202200206A (zh) * 2020-04-28 2022-01-01 瑞士商歐米亞國際公司 包含表面反應碳酸鈣作為賦形劑之顆粒
US12133918B2 (en) 2021-10-01 2024-11-05 Griffin Gamma, Llc Partially pre-gelatinized cassava starch as pharmaceutical excipient
CN116420873B (zh) * 2023-04-12 2024-07-23 南京远见生物工程有限公司 一种虾青素植物多糖配伍制剂及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985459A (en) 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US5747067A (en) 1996-12-06 1998-05-05 Fmc Corporation Co-processed products
US6232351B1 (en) 1998-05-22 2001-05-15 Amway Corporation Co-processed botanical plant composition
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
US6582738B2 (en) 1999-09-13 2003-06-24 Deseret Laboratories, Inc. Process for preparing chewing gum containing a nutritional supplement
US20030213937A1 (en) 2001-02-22 2003-11-20 Isaac Yaniv Precipitated aragonite and a process for producing it
US20030157213A1 (en) 2002-02-19 2003-08-21 Jeffrey Jenkins Nutrient chewing gum
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
EP1712597A1 (en) 2005-04-11 2006-10-18 Omya Development AG Process for preparing precipitated calcium carbonate pigment, especially for use in inkjet printing pater coatings and precipitated calcium carbonate
EP1712523A1 (en) 2005-04-11 2006-10-18 Omya Development AG Precipitated calcium carbonate pigment, especially for use in inkjet printing paper coatings
PT2070991E (pt) 2007-12-12 2010-10-25 Omya Development Ag Processo para produção de carbonato de cálcio precipitado reagido em superfície
EP2168572A1 (en) 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
ATE545682T1 (de) 2009-06-15 2012-03-15 Omya Development Ag Verfahren zur herstellung eines an der oberfläche reagierten calciumcarbonats, das eine schwache säure anwendet
DK2264109T3 (da) 2009-06-15 2012-05-21 Omya Development Ag Fremgangsmåde til fremstilling af overfladereaktivt calciumcarbonat og dets anvendelse
WO2011087629A2 (en) * 2009-12-22 2011-07-21 Fmc Corporation Microcrystalline cellulose and calcium carbonate compositions useful as recompactible pharmaceutical excipients
PT2371766E (pt) 2010-04-01 2013-05-22 Omya Development Ag Processo para preparar um produto de carbonato de cálcio precipitado, material e uso do produto de carbonato de cálcio precipitado
EP2447213B1 (en) 2010-10-26 2015-04-29 Omya International AG Production of high purity precipitated calcium carbonate
SI2524898T1 (sl) 2011-05-16 2015-10-30 Omya International Ag Postopek za proizvodnjo oborjenega kalcijevega karbonata iz odpadne mlete papirne kaše
IN2014MN02048A (es) 2012-03-23 2015-08-14 Omya Int Ag
EP2719373B1 (en) * 2012-10-12 2017-04-19 Omya International AG Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture
EP3260115A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
EP3275948A1 (en) * 2016-07-25 2018-01-31 Omya International AG Process for preparing surface-reacted calcium carbonate

Also Published As

Publication number Publication date
WO2020058252A9 (en) 2020-06-04
KR20210061379A (ko) 2021-05-27
EP3852807B1 (en) 2023-05-03
US20220047511A1 (en) 2022-02-17
EP3852807A1 (en) 2021-07-28
AU2019341523A1 (en) 2021-03-04
CN112770777A (zh) 2021-05-07
CN118593436A (zh) 2024-09-06
WO2020058252A1 (en) 2020-03-26
US12115258B2 (en) 2024-10-15
IL281421A (en) 2021-04-29
BR112021002719A2 (pt) 2021-05-11
JP2022500450A (ja) 2022-01-04

Similar Documents

Publication Publication Date Title
AR116461A1 (es) Excipiente de alto rendimiento que comprende celulosa microcristalina co-procesada y carbonato de calcio reaccionado en superficie
MX2021001562A (es) Excipiente de alto rendimiento que comprende celulosa microcristalina co-procesada y carbonato de calcio reaccionado en superficie.
BR112015027743B8 (pt) métodos para preparar frações de lignina termicamente estáveis
BR112012024312A2 (pt) anticorpos biespecíficos
BR112017021126A2 (pt) composição de lignina ativada, método para a sua produção e utilização
BR112012027217A2 (pt) aparelho de formação de produto alimentício.
AR103077A1 (es) Método para la producción de un sistema de administración farmacéutica
MX376173B (es) Material de hoja moldeable en 3d.
AR112226A1 (es) Comprimidos preparados por compresión
BR112018011526A2 (pt) compostos policíclicos como inibidores da tirosina quinase de bruton
IN2015DN02907A (es)
BR112016016582A2 (pt) Processo para o fracionamento de oligossacarídeos a partir de resíduos agrícolas
BR112018013985A2 (pt) glicosídeos de esteviol altamente solúveis
BR112017000453A2 (pt) processos para fabricar um material contendo carbonato de cálcio e para produzir um produto polimérico, material contendo carbonato de cálcio, material particulado, e, usos do processo e de um material particulado.
AR112587A1 (es) Psicosa-6-fosfato fosfatasa, composición para producir d-psicosa que comprende la enzima y métodos para producir d-psicosa utilizando la enzima
ECSP21082195A (es) Formas sólidas de un inhibidor de glyt1
CR20140444A (es) Un sistema y un método para la producción integrada de etanol de primera y segunda generación, y uso de puntos de integración para dicha producción
CL2023002712A1 (es) Composiciones cementicias y métodos relacionados
EP4013835A4 (en) LOW PRESSURE DEPOLYMERIZATION OF LIGNOCELLULOSE BIOMASS
BR112016026678A2 (pt) Método de moagem e meio de moagem
BR112017022596A2 (pt) métodos para a produção de nanocelulose com alto teor de sólidos
BR112016006824A2 (pt) composição pesticida, método para o preparo de uma composição pesticida e uso da celulose microfibrilada
MX2022006320A (es) Composicion para la inhibicion de la produccion de hmf que comprende disacarido de alulosa.
BR112016028535A8 (pt) método para gerar um material à base de madeira sólida e um material derivado de hemicelulose a partir de uma matéria-prima de madeira, e, combustíveis derivado de madeira e líquido
BR112018015118A2 (pt) composição farmacêutica injetável inclusiva de trabectedina para uso externo gastrointestinal e método de fabricação da mesma